Video Experimental Relacionado
Updated: Mar 2, 2026
09:15
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
15.2K
ARNi para trastornos lipídicos: ¿es este el futuro?
Miguel Nassif1, Renata Turrini Jacob Fazoli1, Giuliano Generoso1,2
1Cardiology Center, Hospital Sirio Libanes.
Current opinion in lipidology
|February 28, 2026
Resumen
Las terapias de ARN de interferencia (ARNi), que utilizan fármacos de ARNip (ARN de interferencia pequeño), ofrecen silenciamiento génico dirigido para trastornos lipídicos. Estos tratamientos innovadores muestran una gran promesa en el manejo de la hipercolesterolemia y la reducción del riesgo cardiovascular.
Área de la Ciencia:
- Bioquímica y Biología Molecular
- Genética y Genómica
- Farmacología y Terapéutica
Sus antecedentes:
- Los trastornos lipídicos, incluida la hipercolesterolemia, son factores de riesgo significativos para las enfermedades cardiovasculares ateroscleróticas.
- Los avances en la medicina genética han abierto nuevas vías para las intervenciones terapéuticas.
- El ARN de interferencia (ARNi) es un mecanismo natural de silenciamiento génico con potencial terapéutico.
Objetivo del estudio:
- Revisar los avances actuales en las terapias de ARN de interferencia (ARNi), específicamente los fármacos de ARNip (ARN de interferencia pequeño).
- Evaluar críticamente el posicionamiento clínico de estas terapias novedosas.
- Explorar el papel futuro del ARNi en la remodelación del manejo de lípidos.
Principales métodos:
- Revisión de la literatura actual sobre terapias de ARNi para trastornos lipídicos.
- Análisis de datos clínicos de fármacos de ARNip aprobados y en investigación.
- Evaluación del mecanismo de acción, eficacia, seguridad y aplicaciones potenciales de las terapias de ARNi.
Principales resultados:
- Las terapias de ARNi proporcionan una supresión dirigida y duradera de las proteínas reguladoras de lípidos a nivel del ARNm.
- Inclisirán, una terapia de ARNip aprobada, reduce significativamente los niveles de c-LDL con una dosificación infrecuente.
- Los fármacos de ARNi en investigación se dirigen a la lipoproteína(a), la apolipoproteína C-III y la proteína 3 similar a la angiopoyetina para abordar el riesgo cardiovascular residual.
Conclusiones:
- Las terapias basadas en ARNip representan una tecnología disruptiva en lipidología, que podría transformar la prevención y el tratamiento de las enfermedades cardiovasculares.
- Los agentes de ARNi pueden convertirse en la base del manejo lipídico personalizado, permitiendo regímenes de acción prolongada y combinados.
- Los ensayos en curso son cruciales para confirmar los beneficios cardiovasculares y la seguridad, determinando si el ARNi se convertirá en el futuro estándar de atención.
Videos de Conceptos Relacionados
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.6K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.6K
01:24Overview of Lipid Metabolism
6.2K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.2K
01:26Atherosclerosis III: Management
520
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
520
01:31Transducer Mechanism: Nuclear Receptors
3.8K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
3.8K
01:28Assembly of the Lipid Bilayer in the ER
4.3K
Biological membranes are more than just a barrier separating cell cytoplasm from the outside environment. They are highly dynamic and help maintain the integrity and physiological stability of the cells as well as membrane-bound organelles. Membranes also play vital roles in cell-to-cell and intracellular communication.
A large chunk of any biological membrane is composed of phospholipids. These lipids have a heterogeneous distribution across different subcellular organelles and even between...
A large chunk of any biological membrane is composed of phospholipids. These lipids have a heterogeneous distribution across different subcellular organelles and even between...
4.3K
01:29Pharmacogenomics: Identification of New Drug Targets
53
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
53